V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029196 | 20012446 | 1.67 | 109 | Neo-adjuvant (N) | 2014-09-12 | 2014-09-13 | FEC 100 + DOCETAXEL | 2 | N | 20102865 | FEC + DOCETAXEL |
| 20029197 | 20012447 | 1.71 | 76.3 | Adjuvant (A) | 2017-09-07 | 2017-09-20 | FEC + DOCETAXEL | 02 | null | 20102873 | FEC + DOCETAXEL |
| 20029198 | 20012447 | null | 56 | Adjuvant (A) | 2015-01-21 | 2015-01-24 | FEC + DOCETAXEL | N | N | 20102873 | FEC + DOCETAXEL |
| 20029199 | 20012447 | 1.55 | 92.5 | Neo-adjuvant (N) | 2015-03-15 | 2015-03-15 | FEC + DOCETAXEL | N | null | 20102873 | FEC + DOCETAXEL |
| 20029200 | 20012448 | 1.56 | 67.95 | Adjuvant (A) | 2015-08-13 | 2015-08-23 | FEC 100 + DOCETAXEL | null | N | 20102886 | FEC + DOCETAXEL |
| 20029201 | 20072475 | 1.57 | 65.3 | Curative (C) | 2013-05-12 | 2013-06-10 | FEC + DOCETAXEL | N | null | 20102888 | FEC + DOCETAXEL |
| 20029202 | 20109119 | 1.76 | 71.8 | Adjuvant (A) | 2016-03-20 | 2016-03-20 | FEC + DOCETAXEL | 02 | N | 20102895 | FEC + DOCETAXEL |
| 20029203 | 20109119 | 1.57 | 0 | Adjuvant (A) | 2016-11-28 | 2016-11-30 | FEC + DOCETAXEL | 02 | null | 20102895 | FEC + DOCETAXEL |
| 20029204 | 20109119 | 1.53 | 62.7 | Neo-adjuvant (N) | 2017-05-28 | 2017-06-09 | FEC + DOCETAXEL | null | N | 20102895 | FEC + DOCETAXEL |
| 20029205 | 20109119 | 1.57 | 90 | Adjuvant (A) | 2016-06-19 | 2016-07-11 | FEC 100 + DOCETAXEL | N | N | 20102895 | FEC + DOCETAXEL |
| 20029206 | 20012449 | 1.6 | 78.55 | null | 2016-06-24 | 2016-06-25 | FEC 100 + DOCETAXEL | N | N | 20102913 | FEC + DOCETAXEL |
| 20029207 | 20012449 | 0 | 59 | Adjuvant (A) | 2017-05-10 | 2017-05-26 | FEC + DOCETAXEL | N | N | 20102913 | FEC + DOCETAXEL |
| 20029208 | 20012449 | null | 78.6 | null | null | 2018-02-19 | FEC 100 + DOCETAXEL | null | null | 20102913 | FEC + DOCETAXEL |
| 20029209 | 20012449 | 1.61 | 80.9 | Adjuvant (A) | 2013-04-17 | 2013-04-19 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20102913 | FEC + DOCETAXEL |
| 20029210 | 20012449 | null | 68 | Curative (C) | null | 2014-09-22 | FEC 100 + DOCETAXEL | N | N | 20102913 | FEC + DOCETAXEL |
| 20029211 | 20012449 | 1.58 | 80 | Adjuvant (A) | 2013-10-17 | 2013-10-29 | FEC 100 + DOCETAXEL | 2 | N | 20102913 | FEC + DOCETAXEL |
| 20029212 | 20012450 | 1.75 | 73 | Adjuvant (A) | 2018-03-03 | 2018-03-28 | FEC + DOCETAXEL | N | N | 20102936 | FEC + DOCETAXEL |
| 20029213 | 20012450 | 1.68 | 64.3 | Neo-adjuvant (N) | 2014-11-20 | 2015-01-21 | FEC + DOCETAXEL | N | N | 20102936 | FEC + DOCETAXEL |
| 20029214 | 20012450 | 1.62 | 73.8 | Adjuvant (A) | null | 2017-04-19 | FEC + DOCETAXEL | null | null | 20102936 | FEC + DOCETAXEL |
| 20029215 | 20012451 | 1.71 | 63 | Neo-adjuvant (N) | 2016-11-04 | 2016-11-12 | FEC + DOCETAXEL | 02 | N | 20102953 | FEC + DOCETAXEL |
| 20029216 | 20012451 | 1.72 | 69.7 | Adjuvant (A) | 2018-01-31 | 2018-02-28 | FEC + DOCETAXEL | 2 | N | 20102953 | FEC + DOCETAXEL |
| 20029217 | 20012452 | 1.58 | 108 | Neo-adjuvant (N) | 2016-03-05 | 2016-03-17 | FEC 100 + DOCETAXEL | 2 | N | 20102961 | FEC + DOCETAXEL |
| 20029218 | 20012452 | 1.52 | 70 | Neo-adjuvant (N) | 2013-09-03 | 2013-09-18 | FEC + DOCETAXEL | N | N | 20102961 | FEC + DOCETAXEL |
| 20029219 | 20012453 | 1.82 | 71.75 | Not known (9) | 2015-02-22 | 2015-03-04 | FEC + DOCETAXEL | 02 | N | 20102965 | FEC + DOCETAXEL |
| 20029220 | 20012454 | 1.76 | 57.9 | Adjuvant (A) | 2017-10-16 | 2017-10-27 | FEC + DOCETAXEL | 02 | N | 20102973 | FEC + DOCETAXEL |
| 20029221 | 20012455 | 1.73 | 80 | Adjuvant (A) | 2013-07-02 | 2013-07-03 | FEC + DOCETAXEL | 02 | N | 20102977 | FEC + DOCETAXEL |
| 20029222 | 20012455 | null | 76.8 | Neo-adjuvant (N) | 2015-09-06 | 2015-09-30 | FEC + DOCETAXEL | N | N | 20102977 | FEC + DOCETAXEL |
| 20029223 | 20012456 | null | null | Curative (C) | 2017-03-12 | 2017-03-29 | FEC 100 + DOCETAXEL | N | null | 20102983 | FEC + DOCETAXEL |
| 20029224 | 20012456 | 1.54 | 78.1 | Adjuvant (A) | 2014-02-26 | 2014-02-27 | FEC 60 OR 75 + DOCETAXEL | N | N | 20102983 | FEC + DOCETAXEL |
| 20029225 | 20012456 | 1.63 | 70.6 | Adjuvant (A) | 2015-01-13 | 2015-01-14 | FEC + DOCETAXEL | 02 | N | 20102983 | FEC + DOCETAXEL |
| 20029226 | 20012456 | 1.55 | 99.5 | Neo-adjuvant (N) | 2017-07-27 | 2017-08-02 | FEC + DOCETAXEL | 02 | N | 20102983 | FEC + DOCETAXEL |
| 20029227 | 20012456 | 1.57 | 72.4 | Adjuvant (A) | null | 2013-09-21 | FEC + DOCETAXEL | N | N | 20102983 | FEC + DOCETAXEL |
| 20029228 | 20012457 | 1.67 | 100 | Adjuvant (A) | 2014-12-14 | 2014-12-31 | FEC 100 + DOCETAXEL | N | N | 20102990 | FEC + DOCETAXEL |
| 20029229 | 20012457 | 1.61 | 79.7 | Adjuvant (A) | 2017-02-10 | 2017-02-24 | FEC + DOCETAXEL | 2 | N | 20102990 | FEC + DOCETAXEL |
| 20029230 | 20012458 | null | null | Adjuvant (A) | null | 2014-08-19 | FEC + DOCETAXEL | null | null | 20102993 | FEC + DOCETAXEL |
| 20029231 | 20012458 | null | null | Adjuvant (A) | 2016-06-20 | 2016-06-20 | FEC 100 + DOCETAXEL | N | N | 20102993 | FEC + DOCETAXEL |
| 20029232 | 20012458 | 1.66 | 69.45 | Adjuvant (A) | 2014-12-03 | 2014-12-15 | FEC 100 + DOCETAXEL | 02 | N | 20102993 | FEC + DOCETAXEL |
| 20029233 | 20012459 | 1.58 | 77 | Neo-adjuvant (N) | 2013-06-24 | 2013-07-06 | FEC + DOCETAXEL | 02 | N | 20103001 | FEC + DOCETAXEL |
| 20029234 | 20012459 | 1.65 | 85 | Adjuvant (A) | 2014-06-20 | 2014-06-20 | FEC + DOCETAXEL | 02 | N | 20103001 | FEC + DOCETAXEL |
| 20029235 | 20012460 | 1.55 | 63 | Adjuvant (A) | 2014-02-08 | 2014-02-11 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20103011 | FEC + DOCETAXEL |
| 20029236 | 20012460 | 1.51 | 74 | Neo-adjuvant (N) | 2016-06-05 | 2016-06-12 | FEC + DOCETAXEL | N | N | 20103011 | FEC + DOCETAXEL |
| 20029237 | 20012461 | 1.71 | 62 | Adjuvant (A) | 2017-02-19 | 2017-02-19 | FEC + DOCETAXEL | 02 | N | 20103019 | FEC + DOCETAXEL |
| 20029238 | 20012461 | 1.59 | 68.8 | Curative (C) | 2016-04-01 | 2016-04-22 | FEC 100 + DOCETAXEL | N | N | 20103019 | FEC + DOCETAXEL |
| 20029239 | 20012462 | null | 67.6 | Neo-adjuvant (N) | 2017-10-23 | 2017-11-02 | FEC 100 + DOCETAXEL | N | N | 20103029 | FEC + DOCETAXEL |
| 20029240 | 20012463 | null | null | Adjuvant (A) | 2016-12-13 | 2016-12-26 | FEC 100 + DOCETAXEL | N | N | 20103031 | FEC + DOCETAXEL |
| 20029241 | 20012463 | 1.6 | 59 | Neo-adjuvant (N) | 2014-08-27 | 2014-09-04 | FEC 100 + DOCETAXEL | 2 | null | 20103031 | FEC + DOCETAXEL |
| 20029242 | 20012464 | 0 | 91.1 | Adjuvant (A) | 2017-07-29 | 2017-08-07 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20103037 | FEC + DOCETAXEL |
| 20029243 | 20012464 | 1.7 | 55 | Neo-adjuvant (N) | 2015-03-16 | 2015-03-26 | FEC + DOCETAXEL | 02 | N | 20103037 | FEC + DOCETAXEL |
| 20029244 | 20012464 | 1.7 | 87 | Adjuvant (A) | 2014-09-24 | 2014-10-08 | FEC + DOCETAXEL | N | null | 20103037 | FEC + DOCETAXEL |
| 20029245 | 20012464 | 1.6 | 72 | Adjuvant (A) | null | 2016-11-03 | FEC + DOCETAXEL | N | N | 20103037 | FEC + DOCETAXEL |